PL2656879T3 - Przezskórne układy podania antybiotyków beta-laktamowych - Google Patents
Przezskórne układy podania antybiotyków beta-laktamowychInfo
- Publication number
- PL2656879T3 PL2656879T3 PL13161970T PL13161970T PL2656879T3 PL 2656879 T3 PL2656879 T3 PL 2656879T3 PL 13161970 T PL13161970 T PL 13161970T PL 13161970 T PL13161970 T PL 13161970T PL 2656879 T3 PL2656879 T3 PL 2656879T3
- Authority
- PL
- Poland
- Prior art keywords
- beta
- delivery systems
- transdermal delivery
- lactam antibiotics
- lactam
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2006/054724 WO2008072032A1 (en) | 2006-12-10 | 2006-12-10 | Transdermal delivery systems of beta-lactam antibiotics |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2656879T3 true PL2656879T3 (pl) | 2017-09-29 |
Family
ID=39511305
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06832186T PL2121593T3 (pl) | 2006-12-10 | 2006-12-10 | Przezskórne systemy dostarczania antybiotyków beta-laktamowych |
PL13161970T PL2656879T3 (pl) | 2006-12-10 | 2006-12-10 | Przezskórne układy podania antybiotyków beta-laktamowych |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06832186T PL2121593T3 (pl) | 2006-12-10 | 2006-12-10 | Przezskórne systemy dostarczania antybiotyków beta-laktamowych |
Country Status (8)
Country | Link |
---|---|
US (3) | US20100040548A1 (pl) |
EP (3) | EP2656879B1 (pl) |
JP (1) | JP5324463B2 (pl) |
CN (1) | CN101547898B (pl) |
CA (1) | CA2671938C (pl) |
ES (2) | ES2547258T3 (pl) |
PL (2) | PL2121593T3 (pl) |
WO (1) | WO2008072032A1 (pl) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
WO2008056207A1 (en) | 2006-11-08 | 2008-05-15 | Chongxi Yu | Transdermal delivery systems of peptides and related compounds |
ES2547258T3 (es) * | 2006-12-10 | 2015-10-02 | Chongxi Yu | Sistemas de administración transdérmica de antibióticos beta-lactama |
WO2008093173A1 (en) | 2007-01-31 | 2008-08-07 | Chongxi Yu | Positively charged water-soluble prodrugs of 1h-imidazo[4, 5-c]quinolin-4-amines and related compounds with very high skin penetration rates |
KR20150058566A (ko) | 2007-06-04 | 2015-05-28 | 테크필즈 인크 | 매우 높은 피부 및 막 침투율을 가지는 nsaia 약물전구체 및 이들의 새로운 의약적 용도 |
BRPI0916446A2 (pt) * | 2008-07-15 | 2018-09-11 | Basf Corp | dispositivo, sistema, composição e método para a distribuição de uma composição de dióxido de cloro substancialmente isenta de ânion de oxi- cloro a um tecido |
KR20210123406A (ko) * | 2008-12-04 | 2021-10-13 | 충시 위 | 고투과력을 가진 조성물 및 이의 적용 |
US8311625B2 (en) | 2009-02-04 | 2012-11-13 | Basf Corporation | Chlorine dioxide treatment for biological tissue |
EP4067370A1 (en) * | 2009-05-08 | 2022-10-05 | Chongxi Yu | High penetration prodrug compositions of peptides and peptide related compounds |
CN102803211B (zh) * | 2009-06-10 | 2016-01-27 | 上海泰飞尔生化技术有限公司 | 具有高穿透性的抗微生物剂和抗微生物剂相关化合物的前药组合物 |
RU2016115906A (ru) * | 2009-06-10 | 2018-11-28 | Текфилдз Байокем Ко., Лтд. | Композиции или пролекарства противомикробных и родственных противомикробным соединений, обладающие высокой проникающей способностью |
US9969751B2 (en) | 2009-06-10 | 2018-05-15 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
TWI496577B (zh) * | 2010-06-10 | 2015-08-21 | Shanghai Techfields Biochem Co Ltd | 抗菌劑和抗菌劑相關化合物的高滲透性前藥組合物 |
AR086249A1 (es) * | 2011-05-02 | 2013-11-27 | Aptalis Pharmatech Inc | Composiciones de tabletas de disolucion rapida de administracion vaginal |
JP6445967B2 (ja) | 2012-05-16 | 2018-12-26 | テックフィールズ ファーマ カンパニー リミテッド | 肺疾患の治療のための高浸透性プロドラッグ組成物およびその薬学的組成物 |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
JP5795343B2 (ja) * | 2013-01-23 | 2015-10-14 | チョンシー ユー | β−ラクタム抗生物質の経皮送達システム |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
KR102329764B1 (ko) | 2013-03-15 | 2021-11-23 | 머크 샤프 앤드 돔 코포레이션 | 세프톨로잔 항균성 조성물 |
US20140274991A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
WO2015035376A2 (en) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
CN103539802B (zh) * | 2013-10-15 | 2016-04-27 | 湖北美天生物科技有限公司 | 一种喷沙西林氢碘酸盐的合成方法 |
WO2018090004A2 (en) * | 2016-11-14 | 2018-05-17 | The University Of North Carolina At Chapel Hill | Tuberculosis therapeutic compounds and methods |
SG11202008251TA (en) | 2018-03-02 | 2020-09-29 | Univ Oregon Health & Science | Amide prodrugs of small molecule nuclear receptor modulators |
AU2019397067A1 (en) | 2018-12-12 | 2021-07-22 | Autobahn Therapeutics, Inc. | Novel thyromimetics |
CN113784950A (zh) | 2019-03-01 | 2021-12-10 | 速通医疗公司 | 新型拟甲状腺素药 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2694063A (en) | 1949-07-07 | 1954-11-09 | Leo Pharm Prod Ltd | Quaternary ammonium addition salts of penicillin esters |
DE858699C (de) * | 1949-07-07 | 1952-12-08 | Leo Pharm Prod Ltd | Verfahren zur Herstellung von Estern des Penicillins mit substituierten Aminoalkoholen bzw. deren Salzen oder quaternaeren Ammoniumverbindungen |
US2694061A (en) * | 1949-07-07 | 1954-11-09 | Leo Pharm Prod Ltd | Method of producing aminoalcohol esters of penicillin |
US2694031A (en) * | 1949-07-07 | 1954-11-09 | Leo Pharm Prod Ltd | Hydroiodides of amino esters of penicillin and oil composition thereof |
US2593852A (en) | 1949-11-16 | 1952-04-22 | Bristol Lab Inc | Penicillin amides |
GB759603A (en) | 1952-07-10 | 1956-10-24 | Yvan Villax | Method for the production of esters of penicillin |
GB768347A (en) * | 1953-02-06 | 1957-02-13 | Knud Abildgaard | Sulphanilate salts of amino alcohol esters of penicillin |
US3957764A (en) * | 1969-11-11 | 1976-05-18 | Lovens Kemiske Fabrik Produktionsaktieselskab | 6-aminopenicillanic acid derivatives |
CA996929A (en) * | 1971-04-05 | 1976-09-14 | Kohzi Nakano | Acyloxyalkyl ester derivatives of penicillin |
GB1335317A (en) | 1971-06-23 | 1973-10-24 | Leo Pharm Prod Ltd | Cephalosporin esters salts thereof and methods for their pre paration |
ES409580A1 (es) * | 1972-12-13 | 1975-12-01 | Andreu Sa Dr | Procedimiento para la obtencion de esteres alquilaminoal- quilicos de la alfa-aminobencilpenicilina. |
GB1482910A (en) | 1973-11-23 | 1977-08-17 | Mercer Ltd F B | Commodity packaging |
IT1048274B (it) | 1974-03-02 | 1980-11-20 | Farmaceutici Italia | Esteri di penicilline e di cefauosporine |
ES428213A1 (es) * | 1974-07-12 | 1976-07-16 | Andreu Sa Dr | Procedimiento para la obtencion de esteres dialquilaminoal-quilicos de penicilina. |
GB1569421A (en) * | 1976-06-11 | 1980-06-18 | Beecham Group Ltd | Penicillin compositions |
US4150157A (en) | 1976-06-11 | 1979-04-17 | Beecham Group Limited | Penicillin compositions |
GB1578730A (en) | 1976-06-24 | 1980-11-05 | Beecham Group Ltd | Esters of penicillin antibiotics |
US4215120A (en) * | 1977-07-14 | 1980-07-29 | Beecham Group Limited | Penicillin esters and their preparation |
IL58939A (en) | 1978-12-18 | 1983-03-31 | Meiji Seika Kaisha | 7 alpha-methoxycephalosporin derivatives and their production |
US4311706A (en) | 1980-01-22 | 1982-01-19 | Interx Research Corporation | Novel dopa/dopamine prodrugs |
JPS5852291A (ja) | 1981-09-22 | 1983-03-28 | Kureha Chem Ind Co Ltd | ペニシリン系抗生物質誘導体とその医薬剤 |
JPS58126846A (ja) * | 1982-01-22 | 1983-07-28 | Kaken Pharmaceut Co Ltd | プロピオン酸アミノアルキルエステル誘導体、その製法およびそれを有効成分とする消炎、鎮痛剤 |
US4428935A (en) | 1982-05-24 | 1984-01-31 | Pfizer Inc. | Penicillanic acid dioxide prodrug |
JPS59128392A (ja) | 1982-12-29 | 1984-07-24 | Kureha Chem Ind Co Ltd | セフアロスポリン誘導体及び該誘導体を含有する薬剤 |
FR2542998B1 (fr) | 1983-03-24 | 1986-01-31 | Rhone Poulenc Sante | Nouvelle forme transdermale du dinitrate d'isosorbide |
DE3347128A1 (de) | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
GB2157284B (en) * | 1984-04-11 | 1987-11-04 | Leo Pharm Prod Ltd | 6-b-halopenicillanic acid salts |
DE3789412T2 (de) | 1986-10-02 | 1994-06-30 | Asahi Chemical Ind | Verfahren zur Herstellung von 3-Alkoxymethylcephalosporinen. |
JPH01131181A (ja) * | 1986-10-02 | 1989-05-24 | Asahi Chem Ind Co Ltd | 3−アルコキシメチルセファロスポリン類の製造方法 |
US5321020A (en) * | 1989-03-28 | 1994-06-14 | Pfizer Inc. | Antibacterial 2-carbapenem derivatives |
JP2672363B2 (ja) | 1989-03-29 | 1997-11-05 | 帝人株式会社 | 有機非線形光学材料 |
DE69224294T2 (de) | 1991-10-16 | 1998-08-20 | Richardson Vicks Inc | Verbesserte hautpenetrationssysteme fuer erhoehte topische freisetzung von arzneimitteln |
US5629019A (en) * | 1992-02-27 | 1997-05-13 | Alza Corporation | Formulations with hydrophobic permeation enhancers |
US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
AU721819B2 (en) | 1996-05-10 | 2000-07-13 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
US6011049A (en) | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
SE9900941D0 (sv) | 1998-12-23 | 1999-03-16 | Nomet Management Serv Bv | Novel retinoic acid derivatives and their use |
US6417207B1 (en) | 1999-05-12 | 2002-07-09 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
US6908900B2 (en) | 2001-01-17 | 2005-06-21 | Zimmer & Associates Ag | Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
WO2003022270A1 (en) | 2001-09-13 | 2003-03-20 | Noven Pharmaceuticals, Inc. | Transdermal administration of an enalapril ester |
WO2004009538A1 (en) | 2002-07-23 | 2004-01-29 | Ardenia Investments Ltd. | Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
ES2436606T3 (es) | 2003-03-12 | 2014-01-03 | Celgene Corporation | Compuestos de 7-amido-isoindolilo y sus usos farmacéuticos |
US7052715B2 (en) | 2003-04-11 | 2006-05-30 | All Natural Fmg, Inc. | Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
DE102004025324A1 (de) | 2004-05-19 | 2005-12-08 | Boehringer Ingelheim Vetmedica Gmbh | Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung |
US7074775B2 (en) | 2004-09-14 | 2006-07-11 | Miller Landon C G | Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders |
US20060222692A1 (en) * | 2005-03-31 | 2006-10-05 | Fairfield Clinical Trials Llc | Method and compositions for transdermal administration of antimicrobial medications |
DK2010184T3 (da) | 2006-04-06 | 2013-03-25 | Nupathe Inc | Implatanter til behandlingen af dopamin associerede tilstande |
EP2038251A4 (en) | 2006-07-09 | 2010-04-21 | Techfields Biochem Co Ltd | POSITIVELY LOADED WATER-SOLUBLE PRODRUGS OF ASPIRIN |
WO2008044095A1 (en) | 2006-10-11 | 2008-04-17 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate |
CA2657636C (en) | 2006-07-18 | 2021-11-09 | Techfields Biochem Co. Ltd | Positively charged water soluble prodrugs of ibuprofen with very fast skin penetration rate |
ES2472545T3 (es) | 2006-07-25 | 2014-07-01 | Techfields Biochem Co. Ltd | Profármacos de diclofenaco solubles en agua con carga positiva y con una tasa de penetración en piel muy rápida |
CN101500983B (zh) | 2006-07-26 | 2015-09-16 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性二氟尼柳及相关化合物的前药 |
HUE028425T2 (en) | 2006-08-08 | 2016-12-28 | Techfields Biochem Co Ltd | Positive charged water-soluble prodrugs of aryl and heteroarylacetic acids with very fast skin penetration rate |
US8458932B2 (en) | 2006-08-11 | 2013-06-11 | Alameda Technology, Llc | Optical illusion device |
JP5424880B2 (ja) | 2006-08-15 | 2014-02-26 | テックフィールズ バイオケム カンパニー リミテッド | 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ |
WO2008026776A1 (fr) | 2006-08-31 | 2008-03-06 | Nanocarrier Co., Ltd. | Composition transdermique, composition pharmaceutique transdermique et composition cosmétique transdermique comprenant un ingrédient actif encapsulant une micelle polymère |
CN101506168B (zh) | 2006-09-03 | 2014-12-10 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 |
JP5466006B2 (ja) | 2006-09-03 | 2014-04-09 | テックフィールズ バイオケム カンパニー リミテッド | 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ |
WO2008056207A1 (en) | 2006-11-08 | 2008-05-15 | Chongxi Yu | Transdermal delivery systems of peptides and related compounds |
ES2547258T3 (es) * | 2006-12-10 | 2015-10-02 | Chongxi Yu | Sistemas de administración transdérmica de antibióticos beta-lactama |
WO2008093173A1 (en) | 2007-01-31 | 2008-08-07 | Chongxi Yu | Positively charged water-soluble prodrugs of 1h-imidazo[4, 5-c]quinolin-4-amines and related compounds with very high skin penetration rates |
KR20150058566A (ko) | 2007-06-04 | 2015-05-28 | 테크필즈 인크 | 매우 높은 피부 및 막 침투율을 가지는 nsaia 약물전구체 및 이들의 새로운 의약적 용도 |
US9969751B2 (en) * | 2009-06-10 | 2018-05-15 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
-
2006
- 2006-12-10 ES ES06832186.8T patent/ES2547258T3/es active Active
- 2006-12-10 ES ES13161970.2T patent/ES2633020T3/es active Active
- 2006-12-10 EP EP13161970.2A patent/EP2656879B1/en active Active
- 2006-12-10 JP JP2009540881A patent/JP5324463B2/ja not_active Expired - Fee Related
- 2006-12-10 PL PL06832186T patent/PL2121593T3/pl unknown
- 2006-12-10 EP EP17177947.3A patent/EP3357926A1/en not_active Withdrawn
- 2006-12-10 WO PCT/IB2006/054724 patent/WO2008072032A1/en active Application Filing
- 2006-12-10 EP EP06832186.8A patent/EP2121593B1/en not_active Not-in-force
- 2006-12-10 PL PL13161970T patent/PL2656879T3/pl unknown
- 2006-12-10 CA CA2671938A patent/CA2671938C/en active Active
- 2006-12-10 CN CN200680056580.XA patent/CN101547898B/zh active Active
-
2009
- 2009-06-10 US US12/482,373 patent/US20100040548A1/en not_active Abandoned
-
2012
- 2012-07-16 US US13/550,361 patent/US10233197B2/en not_active Expired - Fee Related
-
2019
- 2019-02-06 US US16/268,637 patent/US20210206782A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3357926A1 (en) | 2018-08-08 |
EP2656879B1 (en) | 2017-06-28 |
US20100040548A1 (en) | 2010-02-18 |
JP5324463B2 (ja) | 2013-10-23 |
CA2671938A1 (en) | 2008-06-19 |
ES2633020T3 (es) | 2017-09-18 |
EP2121593B1 (en) | 2015-06-17 |
CN101547898B (zh) | 2014-09-24 |
US20210206782A1 (en) | 2021-07-08 |
US20130018029A1 (en) | 2013-01-17 |
EP2121593A4 (en) | 2010-09-08 |
US10233197B2 (en) | 2019-03-19 |
CA2671938C (en) | 2017-10-17 |
EP2121593A1 (en) | 2009-11-25 |
PL2121593T3 (pl) | 2015-11-30 |
EP2656879A1 (en) | 2013-10-30 |
WO2008072032A1 (en) | 2008-06-19 |
ES2547258T3 (es) | 2015-10-02 |
JP2010512380A (ja) | 2010-04-22 |
CN101547898A (zh) | 2009-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2121593A4 (en) | TRANSDERMAL ADMINISTRATION SYSTEMS FOR BETA-LACTAM ANTIBIOTICS | |
HK1221477A1 (zh) | 多肽及相關化合物的透皮給藥系統 | |
IL200077A0 (en) | Transdermal delivery systems | |
EP2101745A4 (en) | DISTRIBUTION OF MEDICINAL PRODUCTS | |
HK1203867A1 (en) | Transdermal methods and systems for the delivery of anti-migraine compounds | |
GB2444395B (en) | Delivery devices | |
GB2444394B (en) | Delivery devices | |
ZA200903598B (en) | Lipase variants for pharmaceutical use | |
IL206184A0 (en) | Systems and methods for delivery of materials | |
SI2101740T1 (sl) | Nov nezlorabljiv farmacevtski sestavek, obsegajoč opiode | |
IL196101A0 (en) | C-phenyl 1-thioglucitol compound | |
EP2010162A4 (en) | COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT | |
AU2007205298A8 (en) | Drug combinations | |
EP2070919A4 (en) | SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | |
GB0617222D0 (en) | Antibiotics | |
SI2084270T1 (sl) | Izdelava beta - laktam antibiotikov | |
EP2114404A4 (en) | COMPOUND AND PHARMACEUTICAL COMPOSITION | |
HK1202068A1 (en) | Transdermal delivery systems of beta lactam antibiotics | |
GB2476731B (en) | Delivery devices | |
EP1993591A4 (en) | TARGETED RELEASE OF PHARMACEUTICAL COMPOUNDS | |
AU2006905107A0 (en) | Transdermal delivery of anti-inflammatory agents | |
GB2461433B (en) | Delivery devices | |
GB0811401D0 (en) | Pharmaceutical composition comprising antibiotics | |
AU2007903316A0 (en) | Transdermal delivery of active agents | |
GB0608210D0 (en) | Methods And Devices For Targeted Drug Deposition |